Clasteon · DIN 02245828 · 400 mg · capsule
Limited Use, Reason for Use code 280, 358, 359 requiredMarketed · checked November 17, 2026
StatusLimited Use, Reason for Use code 280, 358, 359 required
Write on scriptone applicable Reason for Use code, 280 or 358 or 359 (criteria below)
Patient paysIf the Reason for Use code is written and the criteria are met, ODB 65 and over pays:
• ODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
• Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
If the criteria are not met, ODB does not pay this product under Limited Use. [Limited Use benefit, Formulary flag]
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 280, 358, 359
Reason for Use code 280
For the control and prophylaxis of hypercalcemia of malignancy.
Coverage limit:
LU Authorization Period: Indefinite
Reason for Use code 358
For the treatment of bony metastases in patients with breast cancer.
Coverage limit:
LU Authorization Period: Indefinite
Reason for Use code 359
For the prevention and treatment of osteolytic lesions in patients with multiple myeloma.
Coverage limit:
LU Authorization Period: Indefinite
1 brand, same coverage
Clasteon · DIN 02245828
Manufacturer: Knight Therapeutics Inc.; listing date 2004-10-14
Health Canada: Marketed since 2025-11-07 · brand CLASTEON · ATC M05BA02 CLODRONIC ACID · form Capsule · route Oral · ingredients CLODRONATE DISODIUM 400 MG · company Knight therapeutics inc. · schedule Prescription
Clasteon: Formulary list price $1.21 per unit (the source does not state the unit; exact figure $1.2083). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02245828)
Source record
DIN 02245828: Clasteon
Raw flags: chronicUseMed=Y, sec12=Y, sec3=Y
Item: 920000212; group id 905; item number 2167; lccId 00124; manufacturer id KNT
Source form: Cap; strength: 400mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $1.2083; ministry $1.2083
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02245828
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=69944
Interchangeable products
Ostac · DIN 01927078 · not recorded
Shortage status: not checked (no credentials)